147 related articles for article (PubMed ID: 14993029)
1. Breast cancer with chest wall progression: treatment with photodynamic therapy.
Cuenca RE; Allison RR; Sibata C; Downie GH
Ann Surg Oncol; 2004 Mar; 11(3):322-7. PubMed ID: 14993029
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
Morrison SA; Hill SL; Rogers GS; Graham RA
J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality.
Allison R; Mang T; Hewson G; Snider W; Dougherty D
Cancer; 2001 Jan; 91(1):1-8. PubMed ID: 11148553
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer.
Khan SA; Dougherty TJ; Mang TS
Eur J Cancer; 1993; 29A(12):1686-90. PubMed ID: 8398295
[TBL] [Abstract][Full Text] [Related]
5. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia.
Monk BJ; Brewer C; VanNostrand K; Berns MW; McCullough JL; Tadir Y; Manetta A
Gynecol Oncol; 1997 Jan; 64(1):70-5. PubMed ID: 8995550
[TBL] [Abstract][Full Text] [Related]
7. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies.
Schweitzer VG
Lasers Surg Med; 2001; 29(4):305-13. PubMed ID: 11746107
[TBL] [Abstract][Full Text] [Related]
8. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients.
Gayl Schweitzer V
Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.
Wyss P; Schwarz V; Dobler-Girdziunaite D; Hornung R; Walt H; Degen A; Fehr M
Int J Cancer; 2001 Sep; 93(5):720-4. PubMed ID: 11477585
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy in the management of bladder cancer.
Nseyo UO
J Clin Laser Med Surg; 1996 Oct; 14(5):271-80. PubMed ID: 9612193
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Kohoutova D; Haidry R; Banks M; Butt MA; Dunn J; Thorpe S; Lovat L
Scand J Gastroenterol; 2018 May; 53(5):527-532. PubMed ID: 29161901
[TBL] [Abstract][Full Text] [Related]
12. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer.
Taber SW; Fingar VH; Wieman TJ
J Surg Oncol; 1998 Aug; 68(4):209-14. PubMed ID: 9721705
[TBL] [Abstract][Full Text] [Related]
15. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage (Tis-T2N0M0) SqCCa of oral cavity and oropharynx.
Schweitzer VG; Somers ML
Lasers Surg Med; 2010 Jan; 42(1):1-8. PubMed ID: 20077493
[TBL] [Abstract][Full Text] [Related]
16. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer.
Mang TS; Allison R; Hewson G; Snider W; Moskowitz R
Cancer J Sci Am; 1998; 4(6):378-84. PubMed ID: 9853137
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
[TBL] [Abstract][Full Text] [Related]
18. [Photodynamic therapy for gastric cancer].
Mimura S; Narahara H; Uehara H; Otani T; Okuda S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):41-6. PubMed ID: 8546468
[TBL] [Abstract][Full Text] [Related]
19. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
Chan WS; Brasseur N; La Madeleine C; van Lier JE
Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
